← Back to Search

Behavioral Intervention

Gentle Moves for Mild Cognitive Impairment and Dementia (Pro-Home MeC Trial)

Phase 1
Recruiting
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will assess physical activity and cognitive outcomes for inactive older adults with MCI/mild dementia in a memory clinic.

Who is the study for?
This trial is for people aged 50 or older who speak English and have been diagnosed with mild cognitive impairment (MCI) or mild dementia. They should be physically inactive, doing less than 150 minutes of planned exercise per week, and able to sit independently for at least 15 minutes. Those with significant mental or physical disabilities, severe hearing or vision loss, insufficient decision-making capacity, lack of safety awareness, current participation in similar research, or unwillingness to be assigned randomly can't join.
What is being tested?
The 'Pro-Home MeC' study tests a physical activity program called 'Gentle Moves' designed for older adults with MCI or mild dementia in a memory clinic setting. The goal is to see if the program is doable and liked by participants while also checking its effect on brain function.
What are the potential side effects?
Since 'Gentle Moves' involves light physical activities tailored for older adults with cognitive impairments, side effects might include typical exercise-related issues such as muscle soreness or fatigue but are expected to be minimal given the gentle nature of the exercises.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility of NIH Toolbox Cognition Battery
Program Acceptability
Program Feasibility
Secondary study objectives
NIH Toolbox Cognition Battery scores

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Gentle MovesExperimental Treatment1 Intervention
Three-month physical activity intervention.
Group II: Usual CareActive Control1 Intervention
Usual care provided by neuropsychologist.

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
640 Previous Clinical Trials
1,568,761 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,802 Previous Clinical Trials
28,193,953 Total Patients Enrolled

Media Library

Gentle Moves (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05771064 — Phase 1
Mild Cognitive Impairment Clinical Trial 2023: Gentle Moves Highlights & Side Effects. Trial Name: NCT05771064 — Phase 1
Mild Cognitive Impairment Research Study Groups: Usual Care, Gentle Moves
Gentle Moves (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05771064 — Phase 1
Mild Cognitive Impairment Patient Testimony for trial: Trial Name: NCT05771064 — Phase 1
~3 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top